The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), under the Ministry of Ayush, concluded a five-day capacity-building program at its headquarters in Ghaziabad from September 8 to 12, 2025. The program aimed to strengthen the regulatory framework, quality assurance, and standardization of Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) drugs.
The training brought together 27 participants from various regulatory bodies, research councils, pharmaceutical industries, and academic institutions across India. It was designed to equip professionals with advanced knowledge and practical experience in pharmacopoeial standards and Good Manufacturing Practices (GMP).
Program Highlights
The comprehensive curriculum combined expert-led lectures with hands-on laboratory sessions and field visits to provide a holistic learning experience:
- Days 1 & 2: Sessions focused on Pharmacognostic Identification, Phytochemical Analysis, and GMP compliance. Participants received practical training in the Pharmacognosy and Chemistry laboratories.
- Day 3: The day included lectures on shelf-life studies and regulatory frameworks, followed by industry visits to Dr. Willmar Schwabe India Pvt. Ltd. and Hamdard Laboratories for real-world exposure to manufacturing practices.
- Day 4: Sessions covered Microbiological & Pharmacological Evaluations, the standardization of metal and mineral drugs, and regulatory aspects. Participants also visited the on-site Herbal Garden.
- Day 5: The program concluded with discussions on NABL Accreditation, GMP, and the standardization of Siddha drugs.
The program was highly appreciated by participants for its unique blend of theoretical and practical knowledge, reinforcing the national commitment to ensuring the safety, efficacy, and quality of ASU&H drugs. The valedictory session was attended by distinguished guests, including Prof. Dr. K. Ramachandra Reddy, Vice Chancellor of Mahayogi Guru Gorakhnath AYUSH University.